Strengthening links between Uganda and Cambridge in cancer research
A group of senior representatives from the Uganda Cancer Institute have visited Cambridge to strengthen collaborations and explore further opportunities for improving outcomes for cancer patients both in Uganda and in the UK.
The visit was organised as a result of existing links with theĀ Cambridge-Africa ProgrammeĀ and researchersĀ Dr Maike de la RocheĀ (Cancer Research UK Cambridge Institute) andĀ Dr Suzanne TurnerĀ (Department of Pathology and CRUK Cambridge Centre) who work with theĀ Uganda Cancer Institute.
The five visitors from the Uganda Cancer Institute spent a week visiting cancer research facilities at Institutes and Departments across the University and Cambridge University Hospitals, including the Cancer Research UK Cambridge Institute, Departments of Pathology, Paediatrics, Oncology and Radiology, the Hutchison MRC Centre and oncology clinics across the Hospitals.
Cambridge is a world leading city for cancer research and the Uganda Cancer Institute is a Centre of Excellence for the whole East Africa region. Together there is an even greater breadth of knowledge.
Ā Dr Caroline Trotter, Director, Cambridge-Africa
These conversations have sparked several potential areas for collaboration, including training schemes, clinical guideline development, Ā and basic and applied research. Collaborative initiatives have already begun, with the arrival of early career researchers from the UCI to spend two months at the Cancer Research UK Cambridge Institute getting an immersive hands-on experience with our research groups. Further news about the development of other initiatives will be available over the coming months.
At the end of the week, Dr Jackson Orem (Executive Director), Dr Nixon Niyonzima (Director of Research and Training), and Dr Joyce Balagadde Kambugu (Head of Paediatric Oncology) all spoke at the āCancer and Global Healthā event, bringing together academics, clinicians, and wider society to understand and propose solutions to the most pressing challenges in cancer and global health.
By working with Cambridge, the Uganda Cancer Institute has a lot to gain through harnessing the immense capacity in cancer science and applied research in prevention, early detection and diagnosis, as well as effective treatment.
Ā Dr Jackson Orem, Executive Director, Uganda Cancer Institute
Dr Jackson Orem, Executive Director at UCI said āThe team received overwhelming and enthusiastic welcome from the entire leadership and staff of all the Institutions visited. By working with Cambridge, the Uganda Cancer Institute has a lot to gain through harnessing the immense capacity in cancer science and applied research in prevention, early detection and diagnosis, as well as effective treatmentā.
Dr Caroline Trotter, Director at Cambridge-Africa addedĀ āCambridge is a world leading city for cancer research and the Uganda Cancer Institute is a Centre of Excellence for the whole East Africa region. Together there is an even greater breadth of knowledge. We look forward to strengthening links between Uganda and Cambridge through further collaborative projects and combined training schemes, helping to develop the next generation of international cancer researchers.ā
Dr Suzanne Turner, Department of Pathology and CRUK CC said āFurther developments in cancer research will only be realised through collaboration at all levels, both within Cambridge and also globally with international partners. This is one of the main aims of the CRUK Cambridge Centre and our links with the Uganda Cancer Institute are a key example of this. We look forward to working more closely with researchers and clinicians in Uganda to share our expertise but also to benefit from their experience and knowledge in order to end death and disease caused by cancer.ā
Related News
See all news-
New immune pathway offers treatment hope for childhood brain tumours
3rd February 2026
A newly discovered immune pathway could lead to gentler treatments for multiple childhood brain cancers, according to new research from our Gilbertson Group published today in Nature Genetics.
Find out more -
Targeting paused cells could improve chemotherapy for lung and ovarian cancers
3rd February 2026
New research published today in Nature Aging by scientists at the University of Cambridge sheds light on why some lung and ovarian cancers stop responding to chemotherapy, and how this resistance might one day be prevented.
Find out more -
Hot flush treatment has anti-breast cancer activity, study finds
5th January 2026
A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a new Cambridge-led trial has found.
Find out more